Fundraising Fox
Corner Therapeutics
Watertown, US · Founded 2020 · Delaware corporation · 26 employees on LinkedIn
Find your way into Corner Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
92 people can intro you to Andrew
Ask Jeffrey Karp to introduce you to Andrew Cornforth
You →Jeffrey · together at Corner Therapeutics →Andrew
Sign up to find every way you can get introduced to Corner Therapeutics
- Your email: who you already know at Corner Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Corner Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Corner Therapeutics was founded in 2020 by Jonathan Kagan.
NS
Nick SeaverExecutive
AC
Andrew CornforthChief Technology Officer2021–2026Andrew Cornforth is Chief Technology Officer at Corner Therapeutics, where he oversees development of immuno-modulating programs with expertise in lipid nanoparticle formulation, GMP compliance, and manufacturing processes.
RM
Richard MalleyNamed on SEC filing
Board
SA
Steve AltschulerBoard director
AB
Andrew BellingerBoard director
AE
Alan EzekowitzBoard director
Reported raises · per SEC filings
Form D private placements$75.3M disclosed across 2 rounds · 2023–2025
▶$16.8MraisedOct 2025 · 4 investors · PharmaceuticalsRule 506(b)
▶$16.8MraisedOct 2025 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alan EzekowitzDirector
- Nick SeaverExecutive Officer, Director
- Jonathan KaganExecutive Officer, Director
- Steven AltschulerExecutive Officer, Director
- Richard MalleyDirector
- Andrew BellingerDirector
- Andrew CornforthExecutive Officer
- Garrett NicholsExecutive Officer
- Offering amount
- $16.8M
- Amount sold
- $16.8M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$58.5MraisedAug 2025 · 14 investors · PharmaceuticalsRule 506(b)
▶$58.5MraisedAug 2025 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew BellingerDirector
- Nichols GarrettExecutive Officer
- Steve AltschulerExecutive Officer, Director
- Alan EzekowitzDirector
- Nick SeaverExecutive Officer, Director
- Andrew CornforthExecutive Officer
- Richard MalleyDirector
- Jonathan KaganExecutive Officer, Director
- Offering amount
- $63.5M
- Amount sold
- $58.5M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Corner Therapeutics?
- Corner Therapeutics was founded by Jonathan Kagan in 2020.
- How much funding has Corner Therapeutics raised?
- Corner Therapeutics has disclosed $75.3M raised across 2 rounds.
- Where is Corner Therapeutics headquartered?
- Corner Therapeutics is headquartered in Watertown, US.